Defining Long-term Outcomes With Living Donor Liver Transplantation in North America
Kim M. Olthoff(University of Pennsylvania), Abraham Shaked(University of Pennsylvania), Talia Baker(University of Utah), Robert M. Merion(University of Kansas Medical Center), Benjamin Samstein(Cornell University), Chris E. Freise(University of California, San Francisco), James R. Burton(University of Colorado Denver), Brenda W. Gillespie(University of Michigan–Ann Arbor), Abigail R. Smith(Arbor Research Collaborative for Health), Charlotte A. Beil(Arbor Research Collaborative for Health), Elizabeth A. Pomfret(Tufts Medical Center), Abhinav Humar(University of Pittsburgh Medical Center), Michaël Abécassis(University of Arizona), Robert A. Fisher(University of Connecticut), Carl L. Berg(Duke University), David Grant(University of Colorado Boulder), Igal Kam(University of Colorado Denver), Jean C. Emond(Columbia University Irving Medical Center)
Cited by 175
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k